Market Value1,242,966,351
Total Holdings75
File Date2024-02-14
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
BAYZF / Bayer Aktiengesellschaft
OMCL / Omnicell, Inc.
BMRN / BioMarin Pharmaceutical Inc.
AXNX / Axonics, Inc.
OGN / Organon & Co.
IART / Integra LifeSciences Holdings Corporation
RVTY / Revvity, Inc.
PDCO / Patterson Companies, Inc.
TAK / Takeda Pharmaceutical Company Limited - Depositary Receipt (Common Stock)
OLMA / Olema Pharmaceuticals, Inc.
GH / Guardant Health, Inc.
RARE / Ultragenyx Pharmaceutical Inc.
OPRX / OptimizeRx Corporation
PLRX / Pliant Therapeutics, Inc.
THC / Tenet Healthcare Corporation
PRTA / Prothena Corporation plc
ABBV / AbbVie Inc.
AVTR / Avantor, Inc.
HCA / HCA Healthcare, Inc.
SONXD / Sonendo, Inc.
RCM / R1 RCM Inc.
MDT / Medtronic plc
FMS / Fresenius Medical Care AG - Depositary Receipt (Common Stock)
SCTL / Societal CDMO, Inc.
IDYA / IDEAYA Biosciences, Inc.
MXCT / MaxCyte, Inc.
TECH / Bio-Techne Corporation
CNC / Centene Corporation
NVS / Novartis AG - Depositary Receipt (Common Stock)
ANTX / AN2 Therapeutics, Inc.
SIBN / SI-BONE, Inc.
SLP / Simulations Plus, Inc.
QGEN / Qiagen N.V.
ENOV / Enovis Corporation
UTHR / United Therapeutics Corporation
GILD / Gilead Sciences, Inc.
STVN / Stevanato Group S.p.A.
SWAV / Shockwave Medical, Inc.
JNJ / Johnson & Johnson
BCYC / Bicycle Therapeutics plc - Depositary Receipt (Common Stock)
OM / Outset Medical, Inc.
CUTR / Cutera, Inc.
RPHM / Reneo Pharmaceuticals, Inc.
ZNTL / Zentalis Pharmaceuticals, Inc.
OFIX / Orthofix Medical Inc.
KROS / Keros Therapeutics, Inc.
TELA / TELA Bio, Inc.
IRTC / iRhythm Technologies, Inc.
BIIB / Biogen Inc.
GMAB / Genmab A/S - Depositary Receipt (Common Stock)
MIRO / Miromatrix Medical Inc
GSK / GSK plc - Depositary Receipt (Common Stock)
ANAB / AnaptysBio, Inc.
EVH / Evolent Health, Inc.
XENE / Xenon Pharmaceuticals Inc.
CRNX / Crinetics Pharmaceuticals, Inc.
HCAT / Health Catalyst, Inc.
TCMD / Tactile Systems Technology, Inc.
VTRS / Viatris Inc.
SNY / Sanofi - Depositary Receipt (Common Stock)
KIDS / OrthoPediatrics Corp.
ATRC / AtriCure, Inc.
PHLT / Performant Healthcare, Inc.
NEO / NeoGenomics, Inc.
EXEL / Exelixis, Inc.
XRAY / DENTSPLY SIRONA Inc.
INSM / Insmed Incorporated
SNN / Smith & Nephew plc - Depositary Receipt (Common Stock)
AXGN / Axogen, Inc.
IWO / iShares Trust - iShares Russell 2000 Growth ETF
GPCR / Structure Therapeutics Inc. - Depositary Receipt (Common Stock)
KRMD / KORU Medical Systems, Inc.
TNDM / Tandem Diabetes Care, Inc.
HUM / Humana Inc.
NTRA / Natera, Inc.
MODN / Model N, Inc.
LH / Labcorp Holdings Inc.
KRTX / Karuna Therapeutics, Inc.
BHVN / Biohaven Ltd.
OSCR / Oscar Health, Inc.
TMDX / TransMedics Group, Inc.
QDEL / QuidelOrtho Corporation
INSP / Inspire Medical Systems, Inc.
FNA / Paragon 28, Inc.
HALO / Halozyme Therapeutics, Inc.
ATEC / Alphatec Holdings, Inc.